Oral therapeutics used to treat type 2 diabetes and cardiovascular disease often fail to
prevent the progression of disease and their comorbidities. Rooibos (Aspalathus linearis) …

An aspalathin-rich green rooibos extract (Afriplex GRT™) has demonstrated anti-diabetic
and hypolipidemic properties, while also moderately inhibiting CYP3A4 activity, suggesting …

Previous studies have demonstrated antidiabetic effects for rooibos (Aspalathus linearis)
and aspalathin (ASP), one of its main polyphenols. Rooibos, an endemic plant of South …

Rooibos, a shrub-like leguminous bush endemic to South Africa, is traditionally used as a
herbal tea. Unfermented (green) rooibos presents with a much higher polyphenol content, in …

Type 2 diabetic patients possess a two to four-fold-increased risk for cardiovascular
diseases (CVD). Hyperglycemia, oxidative stress associated with endothelial dysfunction …

Xuezhikang (XZK), an extract of Chinese red yeast rice, is recommended as an optimal
choice for patients with coronary heart disease (CHD) with markedly elevated triglyceride …

Metformin is the first line therapy of type 2 diabetics, but continued reduction of their life
expectancy warrants further investigation into alternative treatment strategies. This study …

In a rapid increase in cases of diabetes mellitus worldwide, there has been interested in the
use of plant-derived polyphenols as nutraceuticals to prevent the onset and progression of …

Introduction Obesity is associated with the development of metabolic syndrome, a
conglomerate of cardiometabolic risk factors, which synergistically result in cardiovascular …

The effects of red clover extract and its bioactive components, biochanin A and
formononetin, on the blood glucose and lipid levels of streptozotocin (STZ) induced‐diabetic …